Research ExplorerPublicationsOsteosarcoma

Osteosarcoma

Standard

Osteosarcoma. / Eaton, Bree R; Schwarz, Rudolf; Vatner, Ralph; Yeh, Brian; Claude, Line; Indelicato, Daniel J; Laack, Nadia.

In: PEDIATR BLOOD CANCER, Vol. 68, No. S2, e28352, 05.2021.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Eaton, BR, Schwarz, R, Vatner, R, Yeh, B, Claude, L, Indelicato, DJ & Laack, N 2021, 'Osteosarcoma', PEDIATR BLOOD CANCER, vol. 68, no. S2, e28352. https://doi.org/10.1002/pbc.28352

APA

Eaton, B. R., Schwarz, R., Vatner, R., Yeh, B., Claude, L., Indelicato, D. J., & Laack, N. (2021). Osteosarcoma. PEDIATR BLOOD CANCER, 68(S2), [e28352]. https://doi.org/10.1002/pbc.28352

Vancouver

Eaton BR, Schwarz R, Vatner R, Yeh B, Claude L, Indelicato DJ et al. Osteosarcoma. PEDIATR BLOOD CANCER. 2021 May;68(S2). e28352. https://doi.org/10.1002/pbc.28352

Bibtex

@article{138cd3624f6e4ba88e2bb059cf5302b8,
title = "Osteosarcoma",
abstract = "Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This paper reviews the general management and standard radiotherapy guidelines for osteosarcoma in both North America and Europe in a joined effort between the Children's Oncology Group and International Society of Pediatric Oncology. Standard treatment involves multiagent induction chemotherapy followed by surgical resection for local tumor control and consolidation local control to metastatic sites. Radiotherapy is reserved for cases with a marginal or incomplete resection or for definitive treatment in the case of unresectable disease. We present supporting data for the role of chemotherapy, surgery, and radiation therapy.",
keywords = "Bone Neoplasms/pathology, Child, Humans, Osteosarcoma/pathology, Prognosis, Radiotherapy/methods, Survival Rate",
author = "Eaton, {Bree R} and Rudolf Schwarz and Ralph Vatner and Brian Yeh and Line Claude and Indelicato, {Daniel J} and Nadia Laack",
note = "{\textcopyright} 2020 Wiley Periodicals, Inc.",
year = "2021",
month = may,
doi = "10.1002/pbc.28352",
language = "English",
volume = "68",
journal = "PEDIATR BLOOD CANCER",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "S2",

}

RIS

TY - JOUR

T1 - Osteosarcoma

AU - Eaton, Bree R

AU - Schwarz, Rudolf

AU - Vatner, Ralph

AU - Yeh, Brian

AU - Claude, Line

AU - Indelicato, Daniel J

AU - Laack, Nadia

N1 - © 2020 Wiley Periodicals, Inc.

PY - 2021/5

Y1 - 2021/5

N2 - Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This paper reviews the general management and standard radiotherapy guidelines for osteosarcoma in both North America and Europe in a joined effort between the Children's Oncology Group and International Society of Pediatric Oncology. Standard treatment involves multiagent induction chemotherapy followed by surgical resection for local tumor control and consolidation local control to metastatic sites. Radiotherapy is reserved for cases with a marginal or incomplete resection or for definitive treatment in the case of unresectable disease. We present supporting data for the role of chemotherapy, surgery, and radiation therapy.

AB - Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This paper reviews the general management and standard radiotherapy guidelines for osteosarcoma in both North America and Europe in a joined effort between the Children's Oncology Group and International Society of Pediatric Oncology. Standard treatment involves multiagent induction chemotherapy followed by surgical resection for local tumor control and consolidation local control to metastatic sites. Radiotherapy is reserved for cases with a marginal or incomplete resection or for definitive treatment in the case of unresectable disease. We present supporting data for the role of chemotherapy, surgery, and radiation therapy.

KW - Bone Neoplasms/pathology

KW - Child

KW - Humans

KW - Osteosarcoma/pathology

KW - Prognosis

KW - Radiotherapy/methods

KW - Survival Rate

U2 - 10.1002/pbc.28352

DO - 10.1002/pbc.28352

M3 - SCORING: Review article

C2 - 32779875

VL - 68

JO - PEDIATR BLOOD CANCER

JF - PEDIATR BLOOD CANCER

SN - 1545-5009

IS - S2

M1 - e28352

ER -